Seelos Therapeutics Financial Overview
Seelos Therapeutics's market cap is currently $1.00. The company's EPS TTM is $176.641; its P/E ratio is <0.01; Seelos Therapeutics is scheduled to report earnings on April 25, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
